With the exception of the Missouri media and perhaps, the New York Times, it is now clear that adult stem cells offer tremendous hope for treatments for a wide variety of ailments. The Journal of the American Medical Association reports some good news. From a video presentation:

Adult stem cell therapy has become a standard of care when treating several types of cancer. Now a review of clinical trials involving adult stem cells during the past ten years indicates they are helping patients who have a variety of diseases and even heart trouble. One patient diagnosed with multiple sclerosis says his symptoms are gone. Jennifer Mitchell explains in this week’s JAMA Report…

Dr. Richard Burt and his colleagues at Northeastern University reviewed the outcomes of about twenty-five hundred patients who had stem cell transplants. They found the cells appear to be putting some patients with autoimmune diseases into remission and are offering some improvement in heart patients who have suffered heart attacks… AUDIO:”It’s a whole new approach to these diseases. Rather than just surgery or drugs that you can use, a cellular approach that seems in many different studies to be benefiting the patient.” …

AUDIO:BARRY NOW LEADS AN ACTIVE LIFESTYLE. HERE HE IS WITH THE ICE HOCKEY TEAM HE COACHES. AUDIO:”I’ve had five years of good life. Five years. If I didn’t do the transplant I would probably be in a wheelchair today.”

Remember when embryonic stem cells were going to be a huge issue in the 2008 election? Where are the critics now?

A woman dying of Alzheimer’s has a fever. Should she be given antibiotics? Many people would say yes. But a provocative new study suggests that antibiotics are overused in people dying of dementia diseases and should be considered more carefully because of the growing problem of drug-resistant superbugs. (The Associated Press)

Under criticism that its ads are misleading, Pfizer said Monday that it would cancel a long-running advertising campaign using the artificial heart pioneer Robert Jarvik as a spokesman for its cholesterol drug Lipitor. (New York Times)

A proposed new law regulating in-vitro fertilization in the United Kingdom is under fire from the Church and bioethics groups, who are concerned over the loosening of regulations regarding the procedure. The Human Fertilization and Embryology Bill has finished its passage through the House of Lords and will be debated in the Commons in the near future. (ZENIT)

Selling of body organs is against the law but this practice is thriving in the country. Why? Humans need to survive. Persons suffering from end-stage renal diseases need a kidney transplant to become healthy again. The lack of access to renal care and the high cost of dialysis increase the demand for kidney donors. On the other hand, the starving poor need money to buy food, clothing and other basic commodities. (UPI Asia)

South Korean scientists on Monday said they have successfully used nano and bio technologies to grow nerve, muscle and liver tissues from stem cells. (Therapeutics Daily)